Seroatlas · Human Serome Atlas

JAM2

Junctional adhesion molecule B

Also known as: C21orf43, CD322, JAM-2, JAM-B, JAM2_HUMAN, JAMB, VE-JAM

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P57087
Gene
JAM2
Ensembl
ENSG00000154721
Chromosome
21
Canonical length
298 aa
Protein class
CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins
Subcellular location
Nucleoplasm,Plasma membrane

OverviewNCBI Gene

This gene belongs to the immunoglobulin superfamily, and the junctional adhesion molecule (JAM) family. The protein encoded by this gene is a type I membrane protein that is localized at the tight junctions of both epithelial and endothelial cells. It acts as an adhesive ligand for interacting with a variety of immune cell types, and may play a role in lymphocyte homing to secondary lymphoid organs. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2012]

Canonical amino-acid sequenceUniProt

298 residues, UniProt reviewed canonical sequence.

>P57087|JAM2
     1  MARRSRHRLL LLLLRYLVVA LGYHKAYGFS APKDQQVVTA VEYQEAILAC KTPKKTVSSR
    61  LEWKKLGRSV SFVYYQQTLQ GDFKNRAEMI DFNIRIKNVT RSDAGKYRCE VSAPSEQGQN
   121  LEEDTVTLEV LVAPAVPSCE VPSSALSGTV VELRCQDKEG NPAPEYTWFK DGIRLLENPR
   181  LGSQSTNSSY TMNTKTGTLQ FNTVSKLDTG EYSCEARNSV GYRRCPGKRM QVDDLNISGI
   241  IAAVVVVALV ISVCGLGVCY AQRKGYFSKE TSFQKSNSSS KATTMSENDF KHTKSFII

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against JAM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
60 nTPM

Expression across tissuesHPA

Tissue

  • placenta: 60 nTPM
  • basal ganglia: 21 nTPM
  • midbrain: 20 nTPM
  • adipose tissue: 19 nTPM
  • ovary: 19 nTPM
  • cerebral cortex: 19 nTPM

Single-cell type

  • sertoli cells: 322 nCPM
  • vascular endothelial cells: 269 nCPM
  • bergmann glia: 151 nCPM
  • astrocytes: 115 nCPM
  • pituicytes/fscs: 108 nCPM
  • microglia: 101 nCPM

Immune cell

  • naive B-cell: 0.6 nTPM
  • NK-cell: 0.6 nTPM
  • basophil: 0.4 nTPM
  • plasmacytoid DC: 0.4 nTPM
  • neutrophil: 0.3 nTPM
  • memory CD8 T-cell: 0.2 nTPM

Brain region

  • spinal cord: 50 nTPM
  • medulla oblongata: 48 nTPM
  • thalamus: 47 nTPM
  • cerebellum: 43 nTPM
  • midbrain: 41 nTPM
  • white matter: 40 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about JAM2.

Disease | AllUniProt

Conditions JAM2 is implicated in, by any mechanism.

Disease | GeneticClinVar

8 pathogenic / likely-pathogenic of 89 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.7
gnomAD pLI
0.01
gnomAD missense Z
1.08
DepMap mean gene effect
-0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of JAM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads JAM2 as an antibody target. Whether an autoantibody or antibody against JAM2 could matter depends on whether native JAM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

JAM2 is annotated at the cell surface, where native JAM2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label JAM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/JAM2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...